204 related articles for article (PubMed ID: 23948507)
1. Hsp90 inhibits α-synuclein aggregation by interacting with soluble oligomers.
Daturpalli S; Waudby CA; Meehan S; Jackson SE
J Mol Biol; 2013 Nov; 425(22):4614-28. PubMed ID: 23948507
[TBL] [Abstract][Full Text] [Related]
2. Stress-inducible phosphoprotein 1 (HOP/STI1/STIP1) regulates the accumulation and toxicity of α-synuclein in vivo.
Lackie RE; de Miranda AS; Lim MP; Novikov V; Madrer N; Karunatilleke NC; Rutledge BS; Tullo S; Brickenden A; Maitland MER; Greenberg D; Gallino D; Luo W; Attaran A; Shlaifer I; Del Cid Pellitero E; Schild-Poulter C; Durcan TM; Fon EA; Duennwald M; Beraldo FH; Chakravarty MM; Bussey TJ; Saksida LM; Soreq H; Choy WY; Prado VF; Prado MAM
Acta Neuropathol; 2022 Nov; 144(5):881-910. PubMed ID: 36121476
[TBL] [Abstract][Full Text] [Related]
3. HSP90 Co-Chaperone, CacyBP/SIP, Protects α-Synuclein from Aggregation.
Bohush A; Filipek A
Cells; 2020 Oct; 9(10):. PubMed ID: 33049998
[TBL] [Abstract][Full Text] [Related]
4. The molecular chaperone Hsp90 modulates intermediate steps of amyloid assembly of the Parkinson-related protein alpha-synuclein.
Falsone SF; Kungl AJ; Rek A; Cappai R; Zangger K
J Biol Chem; 2009 Nov; 284(45):31190-9. PubMed ID: 19759002
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the non-fibrillar α-synuclein oligomers.
Hong DP; Han S; Fink AL; Uversky VN
Protein Pept Lett; 2011 Mar; 18(3):230-40. PubMed ID: 20858207
[TBL] [Abstract][Full Text] [Related]
6. Co-aggregation of pro-inflammatory S100A9 with α-synuclein in Parkinson's disease: ex vivo and in vitro studies.
Horvath I; Iashchishyn IA; Moskalenko RA; Wang C; Wärmländer SKTS; Wallin C; Gräslund A; Kovacs GG; Morozova-Roche LA
J Neuroinflammation; 2018 Jun; 15(1):172. PubMed ID: 29866153
[TBL] [Abstract][Full Text] [Related]
7. Amyloid-Beta Peptides Trigger Aggregation of Alpha-Synuclein In Vitro.
Köppen J; Schulze A; Machner L; Wermann M; Eichentopf R; Guthardt M; Hähnel A; Klehm J; Kriegeskorte MC; Hartlage-Rübsamen M; Morawski M; von Hörsten S; Demuth HU; Roßner S; Schilling S
Molecules; 2020 Jan; 25(3):. PubMed ID: 32013170
[TBL] [Abstract][Full Text] [Related]
8. A Novel Hsp90 Inhibitor Activates Compensatory Heat Shock Protein Responses and Autophagy and Alleviates Mutant A53T α-Synuclein Toxicity.
Xiong R; Zhou W; Siegel D; Kitson RR; Freed CR; Moody CJ; Ross D
Mol Pharmacol; 2015 Dec; 88(6):1045-54. PubMed ID: 26405178
[TBL] [Abstract][Full Text] [Related]
9. Early stages of aggregation of engineered α-synuclein monomers and oligomers in solution.
Li X; Dong C; Hoffmann M; Garen CR; Cortez LM; Petersen NO; Woodside MT
Sci Rep; 2019 Feb; 9(1):1734. PubMed ID: 30741954
[TBL] [Abstract][Full Text] [Related]
10. Applying chaperones to protein-misfolding disorders: molecular chaperones against α-synuclein in Parkinson's disease.
Chaari A; Hoarau-Véchot J; Ladjimi M
Int J Biol Macromol; 2013 Sep; 60():196-205. PubMed ID: 23748003
[TBL] [Abstract][Full Text] [Related]
11. Membrane interactions of oligomeric alpha-synuclein: potential role in Parkinson's disease.
van Rooijen BD; Claessens MM; Subramaniam V
Curr Protein Pept Sci; 2010 Aug; 11(5):334-42. PubMed ID: 20423294
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase 6 regulates cytotoxic α-synuclein accumulation through induction of the heat shock response.
Du Y; Wang F; Zou J; Le W; Dong Q; Wang Z; Shen F; Yu L; Li Y
Neurobiol Aging; 2014 Oct; 35(10):2316-28. PubMed ID: 24866403
[TBL] [Abstract][Full Text] [Related]
13. Characterizing the inhibition of α-synuclein oligomerization by a pharmacological chaperone that prevents prion formation by the protein PrP.
Dong C; Garen CR; Mercier P; Petersen NO; Woodside MT
Protein Sci; 2019 Sep; 28(9):1690-1702. PubMed ID: 31306510
[TBL] [Abstract][Full Text] [Related]
14. HDAC6-mediated Hsp90 deacetylation reduces aggregation and toxicity of the protein alpha-synuclein by regulating chaperone-mediated autophagy.
Du Y; Yang X; Li Z; Le W; Hao Y; Song Y; Wang F; Guan Y
Neurochem Int; 2021 Oct; 149():105141. PubMed ID: 34298079
[TBL] [Abstract][Full Text] [Related]
15. Brain-permeable small-molecule inhibitors of Hsp90 prevent alpha-synuclein oligomer formation and rescue alpha-synuclein-induced toxicity.
Putcha P; Danzer KM; Kranich LR; Scott A; Silinski M; Mabbett S; Hicks CD; Veal JM; Steed PM; Hyman BT; McLean PJ
J Pharmacol Exp Ther; 2010 Mar; 332(3):849-57. PubMed ID: 19934398
[TBL] [Abstract][Full Text] [Related]
16. Isolation of a human single chain antibody fragment against oligomeric alpha-synuclein that inhibits aggregation and prevents alpha-synuclein-induced toxicity.
Emadi S; Barkhordarian H; Wang MS; Schulz P; Sierks MR
J Mol Biol; 2007 May; 368(4):1132-44. PubMed ID: 17391701
[TBL] [Abstract][Full Text] [Related]
17. Modulation of the extent of structural heterogeneity in α-synuclein fibrils by the small molecule thioflavin T.
Kumar H; Singh J; Kumari P; Udgaonkar JB
J Biol Chem; 2017 Oct; 292(41):16891-16903. PubMed ID: 28760825
[TBL] [Abstract][Full Text] [Related]
18. Heme Stabilization of α-Synuclein Oligomers during Amyloid Fibril Formation.
Hayden EY; Kaur P; Williams TL; Matsui H; Yeh SR; Rousseau DL
Biochemistry; 2015 Aug; 54(30):4599-610. PubMed ID: 26161848
[TBL] [Abstract][Full Text] [Related]
19. Curcumin-glucoside, a novel synthetic derivative of curcumin, inhibits α-synuclein oligomer formation: relevance to Parkinson's disease.
Gadad BS; Subramanya PK; Pullabhatla S; Shantharam IS; Rao KS
Curr Pharm Des; 2012; 18(1):76-84. PubMed ID: 22211690
[TBL] [Abstract][Full Text] [Related]
20. Convergence of heat shock protein 90 with ubiquitin in filamentous alpha-synuclein inclusions of alpha-synucleinopathies.
Uryu K; Richter-Landsberg C; Welch W; Sun E; Goldbaum O; Norris EH; Pham CT; Yazawa I; Hilburger K; Micsenyi M; Giasson BI; Bonini NM; Lee VM; Trojanowski JQ
Am J Pathol; 2006 Mar; 168(3):947-61. PubMed ID: 16507910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
